Research identifies how viral respiratory infection damages macrophages and suggests treatment with a pre-existing FDA approved drug.

A study led by the University of Texas Health Science Center at San Antonio found women had a 31% greater risk of developing ...

In pediatric patients aged 6 months to 5 years, the VE of mRNA-1273 against symptomatic infection was modest after a single dose and strong after a second dose.

The CDC has issued interim effectiveness estimates for the 2024-2025 seasonal influenza and 2024-2025 COVID-19 vaccines.

Bispecific antibodies targeting multiple SARS-CoV-2 sites offer enhanced neutralization against emerging variants, advancing ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Developing myalgic encephalomyelitis/chronic fatigue syndrome is significantly more likely after a case of COVID-19, an important connection for rheumatologists as they sort through symptoms and ...

Some 23% of people infected with SARS-CoV-2 between 2021 and 2023 developed long COVID, and in more than half of them the ...

According to a study of the COVICAT cohort, almost one in four people infected with SARS-CoV-2 suffered from long-COVID. Long-COVID continues to impact many, with symptoms lasting years in some cases.

Scientists reveal that reactivation of Epstein-Barr virus (EBV), driven by TGFβ-induced immune suppression, is a key driver ...

The pandemic hit Manchester much like it did elsewhere in the country, and across the world - suddenly and shockingly, ...